对TFPI抑制X因子激活的新视角
Fabian Santiago1, Amandeep Kaur1, Shannon Bride2
1Department of Applied Mathematics, University of California Merced, Merced, California, United States of America.
PLoS computational biology
|November 15, 2024
概括
组织因子通路抑制剂 (TFPI) 调节血液凝块的形成. 这项研究表明,直接和间接的TFPI通路都至关重要,在流量条件下,直接结合对于有效的凝血调节至关重要.
科学领域:
- 生物化学 生物化学
- 生理学 生理学 生理学
- 计算生物学 计算生物学
背景情况:
- 凝血是血管修复的重要过程,涉及复杂的生物化学反应.
- 组织因子通路抑制剂 (TFPI) 通过抑制X因子激活来关键调节凝血的启动.
- 现有的TFPI抑制模型对直接与间接途径及其速率缺乏明确性,特别是在生理流动下.
研究的目的:
- 重新评估TFPI的直接和间接抑制途径的生化方案和速率.
- 研究这些途径在静态和流动条件下对X因子激活抑制的贡献.
主要方法:
- 利用适应性大都会方法对现有实验数据集进行参数估计.
- 开发了一个包含直接和间接TFPI抑制途径的计算模型.
- 将生理流动动力学集成到模型中,以评估路径贡献.
主要成果:
- 直接和间接的TFPI抑制途径对于准确建模静态实验数据至关重要.
- 在生理流下,直接的TFPI结合是有效抑制X因子激活的必要条件.
- 流动通过去除溶液相复合物来减少间接途径的抑制作用.
结论:
- 这项研究提供了对TFPI在血液凝固中的双重抑制机制的更全面的了解.
- 在动态的生理环境中,直接的TFPI通路对于有效的凝血调节至关重要.
- 准确的凝血建模需要考虑抑制途径和流动动力学.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Extrinsic and Intrinsic Pathways of Hemostasis
5.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.7K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Clot Retraction and Fibrinolysis
4.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.2K
Transcription Elongation Factors
10.8K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
10.8K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K


